Absence Myoclonic

This article describes a disease called Absence Myclonic, which is a serious neurological disorder that affects people of all ages.

Absence myclonic seizure (AMS) is an episodic loss of consciousness, usually associated with bilateral rhythmic attacks of myoclonus involving the facial muscles or



Absence seizures are conditions associated with a short-term loss of consciousness. Several synonyms are used in medicine to refer to this defect, including "epileptic seizure" or "absence state." Translated from Latin, the term means “absence,” which accurately describes the essence of this borderline neurological disorder. These forms are very



Absence Myoclonic: Description and Characteristics

Absence myoclonic is a form of epileptic convulsive condition characterized by complex absence seizures and bilateral rhythmic myoclonus, predominantly in the muscles of the face and upper extremities. This neurological disorder affects the functioning of the brain and can cause temporary loss of consciousness and control of the body.

Absence seizures are brief epileptic seizures that are characterized by a sudden and complete cessation of brain activity. In the case of absence seizures of the myoclonic type, these attacks are accompanied by rhythmic convulsive contractions of the muscles of the face and upper limbs. Myoclonus is an involuntary, rapid and rhythmic contraction of muscles that may be visible as a tic or tremble.

Absence myoclonic seizures are common in children and may begin in early childhood or adolescence. The attacks usually last no more than a few seconds and can occur many times throughout the day. During absence seizures, patients may appear absent or withdrawn, their attention may be impaired, and they may become unresponsive to their environment.

The causes of myoclonic absence seizure are not fully understood, but it is believed that genetic factors, brain disorders and chemical imbalances may play a role in its development. Diagnosis is usually based on clinical manifestations and electroencephalography (EEG), which detects epileptic activity in the brain.

Treatment for myoclonic absence seizure usually involves the use of anticonvulsants, such as sodium valproate or lamotrigine, to reduce the frequency and intensity of seizures. In addition, patients may be offered other treatments, including surgery, if seizures are not controlled by medication.

Although absence myoclonic disorder can be chronic and affect patients' quality of life, regular follow-up with a doctor and adherence to treatment recommendations can help manage the condition. Early diagnosis and timely treatment are also important factors to achieve the best results and reduce possible complications.

In conclusion, absence myoclonic is a form of epileptic seizure disorder characterized by complex absence seizures and bilateral rhythmic myoclonus. It is a neurological disorder that can affect the lives of patients, especially children. However, with proper diagnosis and treatment, most patients with myoclonic absence seizures can achieve seizure control and improve their quality of life.